CymitQuimica logo

Pipamperone dihydrochloride

CAS:

Ref. 3D-FF101592

1mg
Discontinued
2mg
Discontinued
10mg
Discontinued
25mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Pipamperone dihydrochloride
Biosynth

    Product Information

    Name:Pipamperone dihydrochloride
    Controlled Product
    Synonyms:
    • 1-[4-(4-Fluorophenyl)-4-oxobutyl]-[1,4?-bipiperidine]-4?-carboxamide dihydrochloride
    Brand:Biosynth
    Description:Pipamperone is a 5-HT2 receptor antagonist that has been shown to be effective in the treatment of premenstrual syndrome. The drug lowers blood levels of estradiol benzoate, which is an active form of estrogen. Pipamperone also blocks the effects of dopamine on the 5-HT2 receptor, which can lead to extrapyramidal side effects. Pipamperone has been shown to be effective in the treatment of premenstrual syndrome and other symptoms related to mood disorders such as depression, anxiety, and irritability. The drug is usually administered orally at a dosage range of 50-300 mg/day for long-term efficacy. In order to determine the effectiveness of pipamperone in humans, it is necessary to measure its activity following administration with an analytical method that can detect its concentration in human serum or plasma. Pipamperone is a fluorescent probe that emits light when excited by ultraviolet light. A fluorescence probe can be used
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:448.4 g/mol
    Formula:C21H32Cl2FN3O2
    Purity:Min. 95%

    Inquiry about discontinued product: Pipamperone dihydrochloride

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.